Dumoulin Elodie
About Dumoulin Elodie
Dumoulin Elodie is a Delegue Pharmaceutique at Bristol-Myers Squibb in New York with over 20 years of experience in the pharmaceutical industry.
Current Position at Bristol-Myers Squibb
Dumoulin Elodie is currently serving as a Delegue Pharmaceutique at Bristol-Myers Squibb. Located in New York, New York, United States, this position highlights her role in the pharmaceutical industry. Her duties likely involve liaising with healthcare professionals, promoting pharmaceutical products, and supporting sales activities in the New York region.
Previous Work Experience at Novartis
Dumoulin Elodie worked at Novartis as a Delegue Pharmaceutique from 2007 to 2016, amassing 9 years of experience. Her role at Novartis involved pharmaceutical sales and marketing activities. This long tenure underscores her expertise in the field and the significant contributions she made to the company.
Past Positions in Lille, France
Dumoulin Elodie held multiple pharmaceutical sales positions in Lille, Hauts-de-France, France. From 2005 to 2006, she worked at Etradi Groupe OCP as a Delegue Pharmaceutique. Prior to that, she was with Laboratoire Arrow Generiques from 2003 to 2004, and briefly at Merck Génériques in 2003 for two months. These roles provided her with foundational experience in the pharmaceutical industry.
Career in Pharmaceutical Sales and Marketing
Dumoulin Elodie's career in the pharmaceutical industry spans over 20 years, beginning in 2003. She has accumulated extensive experience in pharmaceutical sales and marketing across various companies. Her work primarily involves promoting and selling pharmaceutical products, with a special focus on generic pharmaceuticals.
Experience in the United States and France
Dumoulin Elodie has professional experience in both France and the United States. Her international career has allowed her to develop a diverse set of skills and insights into different pharmaceutical markets. The geographic breadth of her experience enhances her ability to navigate complex market dynamics and regulatory landscapes.